5 years ago

Plasmacytoma in patients with multiple myeloma: morphology and immunohistochemistry

Maiia Firsova, Larisa Mendeleeva, Savchenko Valeri, Alla Kovrigina, Maxim Solovev
Background. To study the histological structure and immunohistochemical (IHC) parameters of the plasmacytoma tumor substrate in patients with MM. Methods. The study included 21 patients (10 men/11 women) aged 23 to 73 years old with a newly diagnosed MM complicated by plasmacytoma. Bone plasmacytoma was diagnosed in 14 patients, and extramedullary plasmacytoma was diagnosed in 7 patients. Plasmacytoma tissue specimens were examined using a LEICA DM4000B microscope. Anti-CD56, CD166, CXCR4, Ki-67, c-MYC antibody panels were used for the IHC study of plasmacytoma biopsy. Results. When comparing the morphology of bone and extramedullary plasmacytoma, no significant differences were revealed, however, when the substrate of the extramedullary plasmacytoma was compared to the bone plasmacytoma substrate it was more often represented by tumor cells with immature morphology (57.1% vs. 28.6%). We founded a significant difference in the expression of CD166 in bone and extramedullary plasmacytoma. It was shown that the mean values ​​of the CD166 expression in bone plasmacytoma cells were significantly higher (p = 0.033) and amounted to 36.29 ± 7.61% versus 9.57 ± 8.46% in extramedullary plasmacytoma cells. We noticed that in the cells of the extramedullary plasmacytoma, there were higher values ​​in the Ki-67 index than observed in comparison to the cells of the bone plasmacytoma independent of the cells'morphology. Conclusion. The mechanisms involved in the dissemination of tumor plasma cells are currently unexplored. Our study revealed significant differences in the IHC parameters of the tumor substrate from extramedullary and bone plasmacytoma. Thus, the expression of the CD166 in extramedullary plasmacytoma cells is almost 4 times lower than that in bone plasmacytoma cells, which may indicate the involvement of CD166 in the mechanisms of bone destruction. A high proliferative activity of extramedullary plasmacytoma cells was shown when compared to bone plasmacytoma cells.
You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.